封面
市場調查報告書
商品編碼
1447613

內視鏡液體管理市場 - 按產品類型、按應用、最終用途 - 全球預測,2024 年 - 2032 年

Endoscopy Fluid Management Market - By Product Type, By Application, By End-use - Global Forecast, 2024 - 2032

出版日期: | 出版商: Global Market Insights Inc. | 英文 170 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

在先進內視鏡系統引進的推動下,2024 年至 2032 年間,全球內視鏡液體管理市場規模的CAGR將達到 7.2%。最近,一些尖端系統受到廣泛青睞,因為它們在醫療過程中提供增強的可視化和診斷功能,進一步需要高效的流體管理解決方案。例如,2023 年 12 月,醫療技術公司奧林巴斯推出了最新產品——EVIS X1 內視鏡系統,專為胃腸道 (GI) 從業人員量身定做。

對改善患者治療效果和手術效率的高度重視正在推動醫療保健提供者尋求創新的液體管理技術,以最佳化液體沖洗、抽吸和廢物處理。隨著內視鏡作為重要的診斷和治療工具的不斷發展,對複雜液體管理系統的需求可能會上升,進一步塑造市場成長軌跡。

整個產業分為產品類型、應用、最終用途和地區。

根據應用,腹腔鏡細分市場的市場佔有率將經歷顯著發展,2024 年至 2032 年CAGR為7.6%。隨著腹腔鏡在微創手術中變得越來越普遍,高效的液體管理對於保持可視性和最佳化患者治療效果至關重要。先進的流體管理系統可精確調節沖洗和抽吸,以確保清晰的手術視野,同時最大限度地減少患者的不適。腹腔鏡技術在各個外科專業領域的日益普及,以及對創新液體管理解決方案的更高需求,將促進該細分市場的成長。

2024 年至 2032 年,內視鏡液體管理行業來自門診手術中心的收入將實現 6.9% 的CAGR。隨著門診手術的增加,高效的液體管理對於確保清晰的可視化和最佳的患者治療效果至關重要。門診手術中心 (ASC) 尋求先進的液體管理系統,以提供精確的沖洗和抽吸控制,並提高手術效率,同時最大限度地減少患者不適。隨著 ASC 在提供高品質護理方面繼續發揮重要作用,針對其需求量身定做的創新液體管理解決方案的需求將推動該細分市場的擴張。

歐洲內視鏡液體管理市場從 2024 年到 2032 年將呈現 7% 的CAGR。歐洲醫療機構專注於先進醫療技術和改善患者治療效果,在內視鏡手術期間優先考慮高效的液體管理。先進的流體管理系統可精確控制沖洗和抽吸,以確保清晰的可視化並最大限度地減少患者的不適。不斷發展的歐洲醫療保健基礎設施以及針對特定要求量身定做的創新流體管理解決方案不斷成長的需求也將推動該地區行業的成長。

目錄

第 1 章:方法與範圍

第 2 章:執行摘要

第 3 章:產業洞察

  • 產業生態系統分析
  • 產業影響力
    • 成長動力
      • 微創手術的需求不斷增加
      • 流體管理系統的技術進步
      • 需要內視鏡手術的慢性疾病的盛行率不斷增加
    • 產業陷阱與挑戰
      • 內視鏡手術費用高
  • 成長潛力分析
  • 波特的分析
  • PESTEL分析
  • 報銷場景
  • 監管環境
  • 技術景觀
  • 未來市場趨勢
  • 缺口分析

第 4 章:競爭格局

  • 介紹
  • 公司矩陣分析
  • 公司市佔率分析
  • 競爭定位矩陣
  • 戰略儀表板

第 5 章:市場估計與預測:按產品類型,2018 年 - 2032 年

  • 主要趨勢
  • 內視鏡液體管理系統
  • 內視鏡液體管理配件

第 6 章:市場估計與預測:按應用,2018 - 2032

  • 主要趨勢
  • 關節鏡檢查
  • 腹腔鏡檢查
  • 子宮腔鏡檢查
  • 其他應用

第 7 章:市場估計與預測:按最終用途,2018 - 2032 年

  • 主要趨勢
  • 醫院
  • 診所
  • 門診手術中心
  • 其他最終用戶

第 8 章:市場估計與預測:按地區分類,2018 年 - 2032 年

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 亞太地區其他地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區

第 9 章:公司簡介

  • Arthrex, Inc.
  • B. Braun SE
  • CONMED Corporation
  • Hologic Inc.
  • Johnson & Johnson
  • KARL STORZ SE & Co. KG
  • Medtronic plc
  • Olympus Corporation
  • Richard Wolf GmbH
  • Smith & Nephew
  • STERIS plc
  • STRYKER Corporation
簡介目錄
Product Code: 4281

Global Endoscopy Fluid Management Market size will witness 7.2% CAGR between 2024 and 2032 driven by the introduction of advanced endoscopy systems. Of late, several cutting-edge systems are widely preferred as they offer enhanced visualization and diagnostic capabilities during medical procedures, further necessitating efficient fluid management solutions. For instance, in December 2023, Olympus, a medical technology company, unveiled its latest advancement, the EVIS X1 endoscopy system, tailored for gastrointestinal (GI) practitioners.

The strong focus on improving patient outcomes and procedural efficiency is driving healthcare providers to seek innovative fluid management technologies to optimize fluid irrigation, suction, and waste disposal. With endoscopy continuing to evolve as a crucial diagnostic and therapeutic tool, the demand for sophisticated fluid management systems may rise, further shaping the market growth trajectory.

The overall industry is classified into product type, application, end-use and region.

Based on application, the market share from the laparoscopy segment will undergo significant development while depicting a 7.6% CAGR from 2024 to 2032. As laparoscopy becomes increasingly prevalent in minimally invasive surgeries, efficient fluid management is essential for maintaining visibility and optimizing patient outcomes. Advanced fluid management systems offer precise regulation of irrigation and suction for ensuring a clear operative field while minimizing patient discomfort. The growing adoption of laparoscopic techniques across various surgical specialties along with the higher demand for innovative fluid management solutions will add to the segment growth.

Endoscopy fluid management industry revenue from the ambulatory surgical centers segment will register a 6.9% CAGR from 2024 to 2032. With the rise in outpatient procedures, efficient fluid management has become crucial for ensuring clear visualization and optimal patient outcomes. Ambulatory surgical centers (ASCs) seek advanced fluid management systems to offer precise irrigation and suction control as well as enhancing procedural efficiency while minimizing patient discomfort. As ASCs continue to play a significant role in delivering high-quality care, the demand for innovative fluid management solutions tailored to their needs will propel the segment expansion.

Europe endoscopy fluid management market will showcase a 7% CAGR from 2024 to 2032. With a focus on advancing healthcare technology and improving patient outcomes, European medical facilities are prioritizing efficient fluid management during endoscopic procedures. Advanced fluid management systems offer precise control over irrigation and suction for ensuring clear visualization and minimized patient discomfort. The evolving European healthcare infrastructure and the growing need for innovative fluid management solutions tailored to the specific requirements will also drive the regional industry growth.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definition
  • 1.2 Base estimates & calculations
  • 1.3 Data collection
  • 1.4 Forecast parameters
  • 1.5 Data validation
  • 1.6 Data sources
    • 1.6.1 Primary
    • 1.6.2 Secondary
      • 1.6.2.1 Paid sources
      • 1.6.2.2 Unpaid sources

Chapter 2 Executive Summary

  • 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing demand for minimally invasive procedures
      • 3.2.1.2 Technological advancements in fluid management systems
      • 3.2.1.3 Increasing prevalence of chronic diseases requiring endoscopic procedures
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 High cost of endoscopic procedures
  • 3.3 Growth potential analysis
  • 3.4 Porter's analysis
    • 3.4.1 Supplier power
    • 3.4.2 Buyer power
    • 3.4.3 Threat of new entrants
    • 3.4.4 Threat of substitutes
    • 3.4.5 Industry rivalry
  • 3.5 PESTEL analysis
  • 3.6 Reimbursement scenario
  • 3.7 Regulatory landscape
  • 3.8 Technological landscape
  • 3.9 Future market trends
  • 3.10 Gap analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
  • 4.4 Competitive positioning matrix
  • 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2018 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Endoscopy fluid management systems
  • 5.3 Endoscopy fluid management accessories

Chapter 6 Market Estimates and Forecast, By Application, 2018 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Arthroscopy
  • 6.3 Laparoscopy
  • 6.4 Hysteroscopy
  • 6.5 Other applications

Chapter 7 Market Estimates and Forecast, By End-Use, 2018 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Hospitals
  • 7.3 Clinics
  • 7.4 Ambulatory surgical centers
  • 7.5 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Italy
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
    • 8.4.6 Rest of Asia Pacific
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
    • 8.5.4 Rest of Latin America
  • 8.6 Middle East and Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 South Africa
    • 8.6.3 UAE
    • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

  • 9.1 Arthrex, Inc.
  • 9.2 B. Braun SE
  • 9.3 CONMED Corporation
  • 9.4 Hologic Inc.
  • 9.5 Johnson & Johnson
  • 9.6 KARL STORZ SE & Co. KG
  • 9.7 Medtronic plc
  • 9.8 Olympus Corporation
  • 9.9 Richard Wolf GmbH
  • 9.10 Smith & Nephew
  • 9.11 STERIS plc
  • 9.12 STRYKER Corporation